Isracann Biosciences Acquires Natural Health Medicine Developer And Appoints Natural Health Products Officers
Acquiring Company
Isracann Biosciences
Acquired Company
Health Medicine Developer
Description
Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the Company’s news releases dated February 23, 2022 and March 28, 2022, it has closed its acquisition of Praesidio Health Inc. (“Praesidio”). Pursuant to the definitive agreement dated March 24, 2022 with Praesidio and the shareholders of Praesidio (the “Praesidio Shareholders”), the Company acquired all of the issued and outstanding shares in the capital of Praesidio (the “Praesidio Shares”) for aggregate consideration of C$4,000,000 in common shares (the “Consideration Shares”) in the capital of the Company (the “Transaction”). Praesidio will operate as a wholly-owned subsidiary of the Company.
Quick answer
Isracann Biosciences is acquiring Health Medicine Developer, announced April 13, 2022.
- How much did Isracann Biosciences pay for Health Medicine Developer?
- The deal value was not disclosed.
- What does Isracann Biosciences do?
- Isracann, Israel’s first pure-play cannabis firm, is focused on becoming a premier, low-cost cannabis producer.
Source: Fundz verified event record.
Other recent acquisitions in Hardware and Community And Lifestyle
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Harborside Inc. Acquires Full Ownership Of Seaside, California Store (May 19, 2022)
- Franchise Global To Acquire German Pharmaceutical And Medical Cannabis Products Distributor, Strengthening Its Position In The German Pharmaceutical And Medical Cannabis Market (May 16, 2022)
- Hill'S Pet Nutrition Completes Purchase Of The Manufacturing Facility Of Nutriamo; Marks Hill'S First Canned Plant Facility In Europe (May 2, 2022)
- Glass House Brands Completes Acquisition Of Plus, A Leading California Edibles Brand (April 29, 2022)
- Koios Closes Acquisition Of Retox Beverage Corp. (April 25, 2022)
- Boston Hemp Inc. Acquires Delta-8 High Life Holdings Llc In $2.8 Million Hemp Industry Acquisition, $2.8M (April 15, 2022)
Who to call at Isracann Biosciences, and when
When Isracann Biosciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Isracann Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Isracann Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Isracann Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Isracann Biosciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Health Medicine Developer?
Health Medicine Developer was acquired by Isracann Biosciences. The deal was reported on April 13, 2022. Isracann, Israel’s first pure-play cannabis firm, is focused on becoming a premier, low-cost cannabis producer. Isracann Biosciences is privately held and operates in Information Technology.
When did Isracann Biosciences acquire Health Medicine Developer?
Isracann Biosciences's acquisition of Health Medicine Developer was reported on April 13, 2022. Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the Company’s news releases dated February 23, 2022 and March 28, 2022, it has closed its acquisition of Praesidio Health Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Health Medicine Developer do?
Health Medicine Developer is the company acquired in this transaction. It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.